GSK’s GSK’227 has gained Priority Medicines (PRIME) designation from the EMA for the treatment of relapsed ES-SCLC.

As the number of acute respiratory infections is rising in China, with significant increases in cases of influenza and other ...

But enrollment for all clinical studies of infant RSV vaccines is now on hold due to safety concerns, explained a Dec. 11 ...

Many theories attempt to explain the complex, values-driven factors behind human decision-making – the “elephant” part of the ...

While RSV is not on the CDC’s current list of Nationally Notifiable Diseases like COVID and influenza, a new rule from the ...

Local parent Meghan Coates shared her experience when her child contracted RSV. “We just figured it was another virus running its course. But RSV tends to turn into other things,” she said. Her child ...

Researchers present a new therapeutic tool capable of inhibiting the proliferation of the SARS-CoV-2 virus that causes COVID-19. The results open up new perspectives in the fight against this ...

After several severe RSV cases were reported in a pediatric trial of Moderna's vaccine, the FDA has partially paused testing ...

Following news of RSV lower respiratory tract infections in infants immunized with Moderna’s investigational RNA vaccines, ...

Researchers identified optimal assessment tools for RSV, influenza, and hMPV that accurately supplement the identification of ...

RSV is spread through droplets in the air when the infected cough or sneeze and can be passed on by touching a surface ...

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...